Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:HRC Hill-Rom (HRC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Hill-Rom Stock (NYSE:HRC) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Get Hill-Rom alerts:Sign Up Key Stats Today's Range$155.96▼$155.9650-Day Range$155.05▼$156.1852-Week Range$93.34▼$156.22VolumeN/AAverage Volume656,912 shsMarket Capitalization$10.30 billionP/E Ratio41.92Dividend Yield0.62%Price TargetN/AConsensus RatingN/A Company OverviewHill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.Read More… Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Hill-Rom Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks47th Percentile Overall ScoreHRC MarketRank™: Hill-Rom scored higher than 47% of companies evaluated by MarketBeat, and ranked 676th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Hill-Rom.Read more about Hill-Rom's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth11.49% Earnings GrowthEarnings for Hill-Rom are expected to grow by 11.49% in the coming year, from $6.44 to $7.18 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hill-Rom is 41.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Hill-Rom is 41.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 138.01.Price to Book Value per Share RatioHill-Rom has a P/B Ratio of 5.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for HRC. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldHill-Rom has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHill-Rom does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Hill-Rom is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Hill-Rom will have a dividend payout ratio of 13.37% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.Read more about Hill-Rom's dividend. Sustainability and ESG3.8 / 5Environmental Score-1.10 Short InterestThere is no current short interest data available for HRC. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 2 people have searched for HRC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Hill-Rom insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.69% of the stock of Hill-Rom is held by insiders.Percentage Held by Institutions76.45% of the stock of Hill-Rom is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hill-Rom's insider trading history. Receive HRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter. Email Address HRC Stock News HeadlinesThe Integra Type S HRC is the future of Acura's parts catalogAugust 16, 2024 | msn.comTrump rips Romney as ‘total loser’ while endorsing a potential replacementApril 28, 2024 | msn.comEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 29, 2024 | Paradigm Press (Ad)Who Is The Highest-Grossing Rom-Com Actress Of All Time?April 15, 2024 | msn.comHulu’s New Rom-Com Looks Like a Surefire Hit. There’s Only One Problem.April 13, 2024 | yahoo.comTransgender Day of Visibility is the day to elevate the voices of the marginalized (exclusive)March 31, 2024 | yahoo.comRanking The 25 Greatest Rom-Coms of All-TimeMarch 18, 2024 | msn.comHere Are The Best 37 Rom-Coms Ever MadeFebruary 14, 2024 | yahoo.comSee More Headlines HRC Stock Analysis - Frequently Asked Questions How were Hill-Rom's earnings last quarter? Hill-Rom Holdings, Inc. (NYSE:HRC) announced its quarterly earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.20. Hill-Rom's quarterly revenue was up 13.1% on a year-over-year basis. Does Hill-Rom have any subsidiaries? Hill-Rom subsidiaries include Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and more. What other stocks do shareholders of Hill-Rom own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), PayPal (PYPL), Block (SQ), Meta Platforms (META) and Bank of America (BAC). Company Calendar Last Earnings11/05/2021Today10/28/2024Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & Medical Instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:HRC Previous SymbolNYSE:HB CUSIP43147510 CIK47518 Webwww.hill-rom.com Phone(312) 819-7200Fax812-934-8189Employees10,000Year Founded1929Profitability EPS (Most Recent Fiscal Year)$3.72 Trailing P/E Ratio41.92 Forward P/E Ratio24.22 P/E GrowthN/ANet Income$248.50 million Net Margins8.23% Pretax Margin10.03% Return on Equity23.07% Return on Assets8.96% Debt Debt-to-Equity Ratio0.97 Current Ratio1.38 Quick Ratio1.05 Sales & Book Value Annual Sales$3.02 billion Price / Sales3.41 Cash Flow$9.29 per share Price / Cash Flow16.79 Book Value$28.56 per share Price / Book5.46Miscellaneous Outstanding Shares66,050,000Free Float65,594,000Market Cap$10.30 billion OptionableOptionable Beta0.55 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NYSE:HRC) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hill-Rom Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hill-Rom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.